Research / BLKB / Fundamental state Inspectable configuration
State dimensions Filing 0001280058-23-000006 General Corporate
Debt relative to revenue 20th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
81.47% · OPTIONAL · VALID
Capex intensity 20th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.16% · OPTIONAL · VALID
Operating cash generation 30th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
19.27% · OPTIONAL · VALID
Revenue growth 90th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
14.05% · CORE · VALID
Gross margin 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
52.24% · CORE · VALID
Operating margin 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-2.69% · CORE · VALID
R&D intensity 90th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
14.83% · OPTIONAL · VALID
SBC intensity 65th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
10.42% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 47 states Self-history eligible
Sep 30, 2021 8/8 normalized Level 3 Dec 31, 2021 8/8 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 326.86%
Current 81.47%
Delta -245.39% Capex Intensity Increased
Previous 1.15%
Current 1.16%
Delta 0.02% Cash Generation Decreased
Previous 41.34%
Current 19.27%
Delta -22.07% Growth Increased
Previous 13.01%
Current 14.05%
Delta 1.04% Margin Decreased
Previous 53.72%
Current 52.24%
Delta -1.48% Profitability Decreased
Previous -2.68%
Current -2.69%
Delta -0.01% R And D Intensity Decreased
Previous 15.48%
Current 14.83%
Delta -0.65% Sbc Intensity Decreased
Previous 10.69%
Current 10.42%
Delta -0.27% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.